Palomino Laboratories (PALX) Enterprise Value (2022 - 2025)

Palomino Laboratories (PALX) has 4 years of Enterprise Value data on file, last reported at -$8.1 million in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value fell 5931.21% year-over-year to -$8.1 million; the trailing twelve-month figure through Dec 2025 stood at -$8.1 million (down 5931.21% YoY), and the FY2025 full-year result was -$8.1 million, down 5931.21% from the prior year.
• Enterprise Value fell to -$8.1 million in Q4 2025, from -$7.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$322.0 in Q2 2024 to a low of -$8.1 million in Q4 2025.
• A 4-year average of -$1.5 million and a median of -$500.0 in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value grew 24.0% in 2023 and plunged 2452250.62% in 2025, its largest moves.
• Tracing PALX's Enterprise Value over 4 years: stood at -$500.0 in 2022, then gained by 24.0% to -$380.0 in 2023, then plunged by 35336.05% to -$134657.0 in 2024, then slumped by 5931.21% to -$8.1 million in 2025.
• Business Quant data shows PALX's Enterprise Value at -$8.1 million in Q4 2025, -$7.9 million in Q3 2025, and -$1887.0 in Q2 2025.